Παρασκευή 29 Ιουνίου 2018

[Correspondence] Adjuvant therapy in resectable gastric cancer—the CRITICS trial

We read the final report of the eagerly awaited CRITICS trial1 with interest, since its overall results showed a favourable outcome when compared with the previous landmark studies, INT01162 and MAGIC.3 Population-based data suggest that the approaches established by both studies have been successfully transferred into clinical practice. The authors provide comprehensive follow-up data, including long-term renal function tests, which will be useful to observe after longer follow-up. Reassuringly, toxicity with radiochemotherapy was not excessive versus chemotherapy alone, and the conclusion by Annemieke Cats and colleagues,1 to direct research toward intensification of preoperative strategies, is reasonable.

https://ift.tt/2KwQ3Jz

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου